Measurement of NT-proBNP with LOCI technology in heart failure patients.
The aim of our study was to determine NT-proBNP concentrations in heart failure (HF) patients with a luminescent oxygen channeling immunoassay (LOCI). Seventy HF patients were enrolled. NT-proBNP levels were measured with LOCI method and compared to a reference NT-proBNP assay. LOCI NT-proBNP levels were significantly correlated with the reference NT-proBNP assay and were related to HF severity. LOCI assay demonstrates performances close to the comparative assay for NT-proBNP testing and allows a significant reduction of the time of analysis.